Your search for supplemental oxygen returned 35 results

Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.

Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air

Researchers find oxygen therapy does not improve quality of life, forestall hospitalization, lengthen lives

Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO

Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.

No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen

Annual respiratory syncytial virus-associated hospitalization rates varied from 35.7 to 132.3 per 1000 children aged younger than 6 months.

Gohibic is supplied as a 200mg/20mL solution in a single-dose vial for IV infusion after dilution.

Researchers examined the epidemiology and clinical outcomes of sporadic health care-associated respiratory syncytial virus infection in children.

InflaRx is working to increase supply of the product in the US as quickly as possible.